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ABSTRACT
Acute metabolic encephalopathy is potentially a reversible condition and requires an early diagnosis and management 
to reduce morbidity and mortality, as in under diagnosed patients, permanent damage  can result. Diabetic encephalop-
athy is an emerging complication of both type I and type II diabetes. Besides T1 hperintensities in bilateral basal 
ganglia in diabetic encephalopathy patients, reported in most of the literature reviewed, patients with hyperglycemic 
seizures can present with subcortical hyperintensities , with predilection for occipital lobes. Here, we report a case of 
type II diabetic, 40 year-female patient who was referred for MR brain to our department, presented with acute symp-
toms of delirium, headache and fits, increased serum glucose levels at time of presentation. No T1 hyperintensities 
were identified in basal ganglia, instead the variable pattern of subcortical hyperintensities were identified with postcon-
trast patchy and gyriform enhancement. She was diagnosed with metabolic encephalopathy and referred back to 
referring clinician for adequate management. On follow up, patient improved clinically with insulin therapy. This report 
highlights the importance of early diagnosis of diabetic encephalopathy in patients with variable patterns on MR 
imaging , thus to avoid unnecessary medical treatment and prevent irreversible symptoms.
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C a s e  r e p o r t
Introduction:
Encephalopathy is the state of diffuse cerebral dysfunc-
tion, secondary to systemic causes, metabolic derange-
ments or drug toxicities. Diabetic encephalopathy   has 
shown increased in the incidence as the incidence of 
type I diabetes has increased in recent years (1). 
Clinical presentation is variable, with the delirium being 
the most common presentation. Besides clinical evalua-
tion and laboratory analysis of arterial blood gases and 
blood biochemistry, somatosensory evoked potential 
(SSEP), electroencephalography (EEG), and imaging 
methods like multislice spiral computed tomography 
(MSCT) and magnetic resonance imaging (MRI) are 
also required (2).
Case Report:
We report a known case of, 40 year female afebrile 
patient with uncontrolled type II diabetes on oral 
hypoglycemic drugs for ten years, presented with 
headache for 4 days, delirium for 3 days and fits for 2 
days. Fits initially begin in right upper limb which gradu-
ally progresses and involve whole body with uprolling of 
eyes and frothing from mouth (described as focal 
seizures with secondary generalization). Her neurologi-
cal examination showed normal tone and bulk, reduce 
power in all four limbs and up going plantars bilaterally. 
Her blood pressure was within normal limits 120/80 
mm Hg.  Blood arterial gas analysis was normal with pH 
7.5, pCO2 23.7, pO2 141,  HCO3, Sat O2  and lactate 
1.4. Her blood biochemistry showed increased glucose 
levels of 180 mg/dl and HbA1c of 12 mg%. Complete 
blood count and Electrolytes were within normal limits 
with normal EEG. Her urine analysis was negative for 
ketones. She received stat doses of I/V antibiotics in 
emergency, which were stopped when blood cultures 
came to be negative. She was referred for MR brain for 
further evaluation, which demonstrated T1 and T2 
isointense signals with FLAIR hyperintensities in cortical 
and subcortical region of right posterior parieto-
occipital lobes, showing linear as well as gyriform 
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ment on postcontrast images. These show restriction in 
Diffusion weighted images. Posterior reversible 
encephalopathy syndrome(PRES) and metabolic 
encephalopathy were included in differential diagnosis. 
PRES was excluded as patient’s blood pressure was 
within normal limits and there was no clinical history of 
high blood pressures. Furthermore T2 isointense 
signals and  post contrast gyriform enhancement do 
not favour PRES. Keeping in view the clinical history of 
patient, metabolic encephalopathy was considered the 
top diagnosis despite variable pattern of MR brain 
features. Patient was managed accordingly and 
followed during the course of the treatment which 
showed resolution of the signs and symptoms. Patient 
was discharged  due to which repeat MR brain could 
not be performed. 
Figure 1 : a-T1WI, b-T2WI, c-d FLAIR images.
Figure 2: a-c post contrast images, d-DW image.
Discussion: 
Kinner Wilson, in 1912, defined metabolic encepha-
lopathy for the first time as the state of global cerebral 
dysfunction caused by systemic stress, which has 
variable manifestation from a very mild disorder to deep 
coma with decerebrate rigidity. It has been defined as 
diffuse cerebral dysfunction as well as a systemic 
disorder affecting hemispheres, reticular activating 
system and brainstem causing diffuse brain 
damage(2).
There are multiple causes for metabolic ‘encephalopa-
thy which include chronic organ diseases, electrolyte 
imbalances, hypo- or hyperglycemia, osmotic 
disorders, overdose of medications especially in 
intensive care units, multiple drug toxicity, alcohol or 
toxin abuse.
 
Neuroimaging including CT or MRI are important to 
exclude any organic or structural lesions of the brain. 
Patients with encephalopathy have usually normal CT 
and MRI brain. However, diffuse or focal edema, 
changes in the signal intensities in certain regions can 
provide clue to the diagnosis and underlying extracer-
ebral pathology. Basal ganglia, thalamus, cerebral 
cortex, and hemispheric white matter are usually the 
target regions in metabolic encephalopathy.
  
To the best of the author’s knowledge, literature review 
shows the characteristic appearance of nonketotic 
hyperglycemia (NKHG) is unilateral or asymmetrical 
bilateral lesions of the basal ganglia which are contralat-
eral to the side of the patient’s presenting symptoms. 
Similarly, on non-enhanced CT brain, putamen and / 
caudate nucleus show hyperdensities contralateral to 
the side of patient’s symptoms (3).
 Suárez-Vega VM et al. (4) reported rare case of Nonke-
totic hyperglycemic hemichorea-hemiballism (NHH) 
causing unilateral brain abnormalities, affecting basal 
ganglia and subtle hyperdensity in striatal region on CT 
scan of brain and T1 hyperintensity and T2 hypointen-
sity in the basal ganglia contralateral to the movements 
on MR imaging.
Hyperglycemic seizures are more commonly seen in 
Non-Ketotic hyperglycemia (NKHG). Seizures can be 
focal with or without secondary generalization and 
occasionally occipital lobe seizures or epilepsia partialis 
continua (5). As seen in our patient, she suffered from 
focal seizures with secondary generalization.
3 6P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S V O L .  1 3  ( 4 )   O C T- D E C E M B E R  2 0 1 8
ABSTRACT
Acute metabolic encephalopathy is potentially a reversible condition and requires an early diagnosis and management 
to reduce morbidity and mortality, as in under diagnosed patients, permanent damage  can result. Diabetic encephalop-
athy is an emerging complication of both type I and type II diabetes. Besides T1 hperintensities in bilateral basal 
ganglia in diabetic encephalopathy patients, reported in most of the literature reviewed, patients with hyperglycemic 
seizures can present with subcortical hyperintensities , with predilection for occipital lobes. Here, we report a case of 
type II diabetic, 40 year-female patient who was referred for MR brain to our department, presented with acute symp-
toms of delirium, headache and fits, increased serum glucose levels at time of presentation. No T1 hyperintensities 
were identified in basal ganglia, instead the variable pattern of subcortical hyperintensities were identified with postcon-
trast patchy and gyriform enhancement. She was diagnosed with metabolic encephalopathy and referred back to 
referring clinician for adequate management. On follow up, patient improved clinically with insulin therapy. This report 
highlights the importance of early diagnosis of diabetic encephalopathy in patients with variable patterns on MR 
imaging , thus to avoid unnecessary medical treatment and prevent irreversible symptoms.
Keywords: 
Diabetic encephalopathy, acute metabolic encephalopathy, non ketotic hyperglycemic seizures, MRI, hyperglycemia.
3 7P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S V O L .  1 3  ( 4 )   O C T- D E C E M B E R  2 0 1 8
tion secondary to the ictus can be seen. However, 
Subcortical areas of T2 hyperintensities are seen in 
subset of NKHG patients. The affected regions show T1 
isointense, focal T2 hypointensity in the cortex but 
T2/FLAIR hyperintensities in underlying white matter 
with associated cortical swelling can also be seen. 
Gradient echo images also demonstrate subcortical 
hypointense signals. ADC values are transiently 
reduced, with focal cortical and leptomeningeal 
enhancement. In follow up scans, these can be either 
completely resolved or present as focal gliosis.
There is predilection for occipital lobes along with 
parietal, temporal  and perirolandic cortex. These foci 
correlate with the ictal focus on EEG, which regresses 
with correction of hyperglycemia. Patients usually have 
elevated HbA1C levels.
Differentials for subcortical T2 hyperintensities include 
viral encephalitis, meningitis, hypoxic insult, Moyamoya 
disease. Differentials for leptomeningeal enhancement 
if present also include lymphoma, sarcoidosis and 
metastasis. Clinical history, hyperglycemic state and 
supportive EEG findings are the road map to accurate 
diagnosis.
Treatment usually targets for the correction of hypergly-
cemia, with which there is good response to the control 
of seizures. Thus antiepileptic drugs are not usually 
required except for few cases who may require short 
term management with phenobarbitol or valproic acid. 
In hyperglycemic states, phenytoin is avoided as it 
alters the glycemic control, thus aggravating the 
seizures.
Conclusion:
Diabetic encephalopathy is a potentially reversible 
acute metabolic encephalopathy requires an early 
accurate diagnosis, to plan appropriate management. 
Clinical background of poorly controlled diabetes with 
hyperglycemia, focal seizures with or without secondary 
generalization, in appropriate CT and MR findings are 
helpful to clinch the diagnosis. This report emphasizes 
the importance of metabolic causes of encephalopathy 
thus facilitating the prompt and appropriate manage-
ment.
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